Health · 38 views
Autoimmune disease linked to poor outcomes with myelodysplastic syndrome
Having a preexisting autoimmune disease is an independent risk factor for poor outcomes with myelodysplastic syndrome (MDS), according to a study published in the June issue of Clinical Immunology .
AI Summary
A retrospective study of 161 myelodysplastic syndrome patients who received allogeneic hematopoietic stem cell transplants between 2013 and 2024 found that those with preexisting autoimmune disease (39 patients) experienced poorer transplant outcomes than matched controls. Specifically, the autoimmune group had lower platelet engraftment, higher relapse rates, and reduced leukemia‑free survival and graft‑versus‑host disease‑free, relapse‑free survival, while overall survival and rates of acute or chronic GVHD did not differ.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Training mothers how to respond to babies might reduce the risk of depression after giving birthContinue reading
- STAT+: Hospitals sue – again – to halt Trump administration’s 340B rebate pilotContinue reading
- T-cell research reveals paths to better vaccines for COVID-19 and beyondContinue reading
- Blood cancer study links blood formation and bone healthContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow